CCNE1 Amplification and Overexpression Characterizes Ovarian Clear Cell Carcinoma But Not Ovarian Endometrioid Carcinoma

被引：0
|
作者：
Ayhan, Ayse
Ogawa, Hiroshi
Bahadirli-Talbott, Asli
Wu, Ren-Chin
Sugimura, Haruhiko
Wang, Tian-Li
Shih, Ie-Ming
机构：
[1] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
[2] Seirei Mikatahara Hosp, Hamamatsu, Shizuoka, Japan
[3] Chang Gung Mem Hosp, Taoyuan, Taiwan
[4] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
[5] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 4313192, Japan
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1092
引用
收藏
页码：273A / 274A
页数：2
相关论文
共 50 条
  • [1] CCNE1 Amplification and Overexpression Characterizes Ovarian Clear Cell Carcinoma But Not Ovarian Endometrioid Carcinoma
    Ayhan, Ayse
    Ogawa, Hiroshi
    Bahadirli-Talbott, Asli
    Wu, Ren-Chin
    Sugimura, Haruhiko
    Wang, Tian-Li
    Shih, Ie-Ming
    LABORATORY INVESTIGATION, 2015, 95 : 273A - 274A
  • [2] CCNE1 AMPLIFICATION AND OVEREXPRESSION CHARACTERIZE OVARIAN CLEAR CELL CARCINOMA BUT NOT OVARIAN ENDOMETRIOID CARCINOMA
    Ayhan, A.
    Ogawa, H.
    Wu, R. C.
    Sugimura, H.
    Wang, T. L.
    Shih, I. M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 399 - 399
  • [3] CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis
    Ayhan, Ayse
    Kuhn, Elisabetta
    Wu, Ren-Chin
    Ogawa, Hiroshi
    Bahadirli-Talbott, Ash
    Mao, Tsui-Lien
    Sugimura, Haruhiko
    Shih, Ie-Ming
    Wang, Tian-Li
    MODERN PATHOLOGY, 2017, 30 (02) : 297 - 303
  • [4] CCNE1 Is a Putative Therapeutic Target for ARID1A-Mutated Ovarian Clear Cell Carcinoma
    Kawahara, Naoki
    Yamada, Yuki
    Kobayashi, Hiroshi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
  • [5] CCNE1 Is a Novel Synthetic Lethal Target for ARID1A-Mutated Ovarian Clear Cell Carcinoma
    Kawahara, Naoki
    Yamada, Yuki
    Kawaguchi, Ryuji
    CANCER SCIENCE, 2023, 114 : 1845 - 1845
  • [6] An Immunohistochemical Comparison of Ovarian and Uterine Endometrioid Carcinoma, Endometrioid Carcinoma with Clear Cell Change and Clear Cell Carcinoma
    Lim, D.
    Ip, P.
    Cheung, A.
    Kiyokawa, T.
    Oliva, E.
    LABORATORY INVESTIGATION, 2014, 94 : 293A - 293A
  • [7] An Immunohistochemical Comparison of Ovarian and Uterine Endometrioid Carcinoma, Endometrioid Carcinoma with Clear Cell Change and Clear Cell Carcinoma
    Lim, D.
    Ip, P.
    Cheung, A.
    Kiyokawa, T.
    Oliva, E.
    MODERN PATHOLOGY, 2014, 27 : 293A - 293A
  • [8] Immunohistochemical Comparison of Ovarian and Uterine Endometrioid Carcinoma, Endometrioid Carcinoma With Clear Cell Change, and Clear Cell Carcinoma
    Lim, Diana
    Ip, Philip P. C.
    Cheung, Annie N. Y.
    Kiyokawa, Takako
    Oliva, Esther
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (08) : 1061 - 1069
  • [9] CCNE1 amplification in early-stage ovarian carcinomas
    Rodriguez Villena, A.
    Guerra Alia, E.
    Carretero del Barrio, I.
    Cristobal, E.
    Caniego, T.
    Palacios, J.
    Perez-Mies, B.
    VIRCHOWS ARCHIV, 2024, 485 : S93 - S94
  • [10] The role of CCNE1 amplification in refractory ovarian and endometrial cancer
    Park, J. A.
    Bethany, B.
    Frimer, M.
    Cheng, K.
    John, V. S.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 216 - 216
12345